FTC attacks bogus cancer therapy. The U.S. Federal Trade Commission has filed suit in Seattle, Washington to permanently bar David L. Walker, (individually and doing business as DLW Consulting, Inc.) from claiming that his "CWAT-Treatment: BioResonance Therapy," is effective against cancer. The FTC's lawsuit charges Walker with falsely claiming that his treatment makes surgery, chemotherapy, and other conventional cancer treatments unnecessary and only 15 out of 745 users have not survived. His system, which sold for between $2,400 and $5,200, included herbal products, dietary supplements and an electrical device called the "Molecular Enhancer." The FTC is asking the court to bar the unsubstantiated claims permanently and to order consumer redress. Walker's Web site was taken down a few months ago after the State of Washington's Attorney General filed a similar action.